{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T12:29:57Z","timestamp":1722342597795},"reference-count":46,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,11]]},"DOI":"10.7759\/cureus.9128","type":"journal-article","created":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T12:21:31Z","timestamp":1594470091000},"source":"Crossref","is-referenced-by-count":1,"title":["Tramadol for the Management of Opioid Withdrawal: A Systematic Review of Randomized Clinical Trials"],"prefix":"10.7759","author":[{"given":"Kaushal","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Billy","family":"Stout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hunter","family":"Caskey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"The history of opium and the opiates","volume":"65","author":"Cohen MM","year":"1969","unstructured":"Cohen MM. The history of opium and the opiates. Tex Med. 1969, 65:76-85.","journal-title":"Tex Med"},{"key":"ref2","article-title":"Biochemistry, Endogenous Opioids","author":"Shenoy SS","year":"2020","unstructured":"Shenoy SS, Lui F. Biochemistry, Endogenous Opioids. StatPearls Publishing [Internet], Florida; 2020."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12862","article-title":"Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment","volume":"28","author":"Kosten TR","year":"2019","unstructured":"Kosten TR, Baxter LE. Effective management of opioid withdrawal symptoms: a gateway to opioid dependence treatment. Am J Addict. 2019, 28:55-62. 10.1111\/ajad.12862","journal-title":"Am J Addict"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1604339","article-title":"Treatment of opioid-use disorders","volume":"375","author":"Schuckit MA","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016, 375:357-368. 10.1056\/NEJMra1604339","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","article-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","year":"2013","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Association, Washington DC; 2013. 10.1176\/appi.books.9780890425596"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/add.12551","article-title":"The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study","volume":"109","author":"Degenhardt L","year":"2014","unstructured":"Degenhardt L, Charlson F, Mathers B, Hall WD, Flaxman AD, Johns N, Vos T. The global epidemiology and burden of opioid dependence: results from the global burden of disease 2010 study. Addiction. 2014, 109:1320-1333. 10.1111\/add.12551","journal-title":"Addiction"},{"key":"ref7","unstructured":"National survey on drug use and health. detailed tables. (2015). Accessed: June 15, 2020: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015\/NSDUH-DetTabs-2015.pdf."},{"key":"ref8","unstructured":"Mortality in the United States, 2016. (2017). Accessed. June 16, 2020: https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db293.pdf."},{"key":"ref9","unstructured":"National survey on drug use and health. detailed tables. (2016). Accessed: June 16, 2020: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-DetTabs-2016\/NSDUH-DetTabs-2016.pdf."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization - United States, 1999-2014","volume":"67","author":"Haight SC","year":"2018","unstructured":"Haight SC, Ko JY, Tong VT, Bohm MK, Callaghan WM. Opioid use disorder documented at delivery hospitalization - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2018, 67:845-849. 10.15585\/mmwr.mm6731a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref11","article-title":"Buprenorphine therapy for opioid use disorder","volume":"97","author":"Zoorob R","year":"2018","unstructured":"Zoorob R, Kowalchuk A, Mejia de Grubb M. Buprenorphine therapy for opioid use disorder. Am Fam Physician. 2018, 97:313-320.","journal-title":"Am Fam Physician"},{"key":"ref12","unstructured":"Prescribing policies. states confront opioid overdose epidemic. (2019). Accessed: June 15, 2020: https:\/\/www.ncsl.org\/research\/health\/prescribing-policies-states-confront-opioid-overdose-epidemic.aspx."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1300\/j069v22n04_02","article-title":"Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study","volume":"22","author":"Tamaskar R","year":"2003","unstructured":"Tamaskar R, Parran TV Jr, Heggi A, Brateanu A, Rabb M, Yu J. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study. J Addict Dis. 2003, 22:5-12. 10.1300\/j069v22n04_02","journal-title":"J Addict Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1517\/14656560903037168","article-title":"Opioid dependence treatment: options in pharmacotherapy","volume":"10","author":"Stotts AL","year":"2009","unstructured":"Stotts AL, Dodrill CL, Kosten TR. Opioid dependence treatment: options in pharmacotherapy. Expert Opin Pharmacother. 2009, 10:1727-1740. 10.1517\/14656560903037168","journal-title":"Expert Opin Pharmacother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182312983","article-title":"Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction","volume":"5","author":"Kraus ML","year":"2011","unstructured":"Kraus ML, Alford DP, Kotz MM, et al.. Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Addict Med. 2011, 5:254-263. 10.1097\/ADM.0b013e3182312983","journal-title":"Addict Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/BF00231123","article-title":"Dependence on tramadol","volume":"72","author":"Ehrenreich H","year":"1993","unstructured":"Ehrenreich H, Poser W. Dependence on tramadol. Clin Investig. 1993, 72:76. 10.1007\/BF00231123","journal-title":"Clin Investig"},{"key":"ref17","unstructured":"Tramadol history and statistics. (2018). Accessed. June 05, 2020: https:\/\/drugabuse.com\/tramadol\/history-statistics\/."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2018.12.085","article-title":"An overview of tramadol and its usage in pain management and future perspective","volume":"111","author":"Subedi M","year":"2019","unstructured":"Subedi M, Bajaj S, Kumar MS, Yc M. An overview of tramadol and its usage in pain management and future perspective. Biomed Pharmacother. 2019, 111:443-451. 10.1016\/j.biopha.2018.12.085","journal-title":"Biomed Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra020617","article-title":"Management of drug and alcohol withdrawal","volume":"348","author":"Kosten TR","year":"2003","unstructured":"Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003, 348:1786-1795. 10.1056\/NEJMra020617","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.31887\/DCNS.2007.9.2\/hkleber","article-title":"Pharmacologic treatments for opioid dependence: detoxification and maintenance options","volume":"9","author":"Kleber HD","year":"2007","unstructured":"Kleber HD. Pharmacologic treatments for opioid dependence: detoxification and maintenance options. Dialogues Clin Neurosci. 2007, 9:455-470.","journal-title":"Dialogues Clin Neurosci"},{"key":"ref21","unstructured":"National practice guideline. For the use of medications in the treatment of addiction involving opioid use. (2019). Accessed. June 11, 2020: https:\/\/www.asam.org\/docs\/default-source\/practice-support\/guidelines-and-consensus-docs\/asam-national-practice-guidel...."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"2009","author":"Mattick RP","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009, 2009:CD002209. 10.1002\/14651858.CD002209.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/01.ADM.0000435321.39251.d7","article-title":"Safe methadone induction and stabilization: report of an expert panel","volume":"7","author":"Baxter LE Sr","year":"2013","unstructured":"Baxter LE Sr, Campbell A, Deshields M, et al.. Safe methadone induction and stabilization: report of an expert panel. J Addict Med. 2013, 7:377-386. 10.1097\/01.ADM.0000435321.39251.d7","journal-title":"J Addict Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.07.013","article-title":"Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy","volume":"106","author":"Parran TV","year":"2010","unstructured":"Parran TV, Adelman CA, Merkin B, Pagano ME, Defranco R, Ionescu RA, Mace AG. Long-term outcomes of office-based buprenorphine\/naloxone maintenance therapy. Drug Alcohol Depend. 2010, 106:56-60. 10.1016\/j.drugalcdep.2009.07.013","journal-title":"Drug Alcohol Depend"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001333.pub4","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"2011","author":"Minozzi S","year":"2011","unstructured":"Minozzi S, Amato L, Vecchi S, Davoli M, Kirchmayer U, Verster A. Oral naltrexone maintenance treatment for opioid dependence. Cochrane Database Syst Rev. 2011, 2011:CD001333. 10.1002\/14651858.CD001333.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2011.11071121","article-title":"Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial","volume":"169","author":"Tiihonen J","year":"2012","unstructured":"Tiihonen J, Krupitsky E, Verbitskaya E, et al.. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry. 2012, 169:531-536. 10.1176\/appi.ajp.2011.11071121","journal-title":"Am J Psychiatry"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M758","article-title":"Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol","volume":"44","author":"O'Mara K","year":"2010","unstructured":"O'Mara K, Gal P, Davanzo C. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol. Ann Pharmacother. 2010, 44:1342-1344. 10.1345\/aph.1M758","journal-title":"Ann Pharmacother"},{"key":"ref28","article-title":"Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol","volume":"267","author":"Raffa RB","year":"1993","unstructured":"Raffa RB, Friderichs E, Reimann W, et al.. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther. 1993, 267:331-340.","journal-title":"J Pharmacol Exp Ther"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2165\/11635500-000000000-00000","article-title":"Analgesics in patients with hepatic impairment: pharmacology and clinical implications","volume":"72","author":"Bosilkovska M","year":"2012","unstructured":"Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012, 72:1645-1669. 10.2165\/11635500-000000000-00000","journal-title":"Drugs"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001683","article-title":"Trends in tramadol: pharmacology, metabolism, and misuse","volume":"124","author":"Miotto K","year":"2017","unstructured":"Miotto K, Cho AK, Khalil MA, Blanco K, Sasaki JD, Rawson R. Trends in tramadol: pharmacology, metabolism, and misuse. Anesth Analg. 2017, 124:44-51. 10.1213\/ANE.0000000000001683","journal-title":"Anesth Analg"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsycho.2006.01.010","article-title":"Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol","volume":"73","author":"Epstein DH","year":"2006","unstructured":"Epstein DH, Preston KL, Jasinski DR. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol. Biol Psychol. 2006, 73:90-99. 10.1016\/j.biopsycho.2006.01.010","journal-title":"Biol Psychol"},{"key":"ref32","article-title":"Kaplan and Sadock's Comprehensive Textbook of Psychiatry","author":"Sadock BJ","year":"2017","unstructured":"Sadock BJ, Sadock VA, Ruiz P. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. Lippincott Williams & Wilkins, USA; 2017."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0847-3","article-title":"Modest opioid withdrawal suppression efficacy of oral tramadol in humans","volume":"194","author":"Lofwall MR","year":"2007","unstructured":"Lofwall MR, Walsh SL, Bigelow GE, Strain EC. Modest opioid withdrawal suppression efficacy of oral tramadol in humans. Psychopharmacology (Berl). 2007, 194:381-393. 10.1007\/s00213-007-0847-3","journal-title":"Psychopharmacology (Berl)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2010.08.005","article-title":"Tramadol versus clonidine in management of heroin withdrawl","volume":"3","author":"Chattopadhyay S","year":"2010","unstructured":"Chattopadhyay S, Singh OP, Bhattacharyya A, Sen S, Roy P, Debnath S. Tramadol versus clonidine in management of heroin withdrawl. Asian J Psychiatr. 2010, 3:237-239. 10.1016\/j.ajp.2010.08.005","journal-title":"Asian J Psychiatr"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-010-1919-3","article-title":"Physical dependence potential of daily tramadol dosing in humans","volume":"211","author":"Lanier RK","year":"2010","unstructured":"Lanier RK, Lofwall MR, Mintzer MZ, Bigelow GE, Strain EC. Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl). 2010, 211:457-466. 10.1007\/s00213-010-1919-3","journal-title":"Psychopharmacology (Berl)"},{"key":"ref36","article-title":"Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids","volume":"38","author":"Hennies HH","year":"1988","unstructured":"Hennies HH, Friderichs E, Schneider J. Receptor binding, analgesic and antitussive potency of tramadol and other selected opioids. Arzneimittelforschung. 1988, 38:877-880.","journal-title":"Arzneimittelforschung"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.111.181131","article-title":"Discriminative stimulus effects of tramadol in humans","volume":"338","author":"Duke AN","year":"2011","unstructured":"Duke AN, Bigelow GE, Lanier RK, Strain EC. Discriminative stimulus effects of tramadol in humans. J Pharmacol Exp Ther. 2011, 338:255-262. 10.1124\/jpet.111.181131","journal-title":"J Pharmacol Exp Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1080\/10550490500528712","article-title":"Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study","volume":"15","author":"Threlkeld M","year":"2006","unstructured":"Threlkeld M, Parran TV, Adelman CA, Grey SF, Yu Y. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study. Am J Addict. 2006, 15:186-191. 10.1080\/10550490500528712","journal-title":"Am J Addict"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.665728","article-title":"Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial","volume":"31","author":"Zarghami M","year":"2012","unstructured":"Zarghami M, Masoum B, Shiran MR. Tramadol versus methadone for treatment of opiate withdrawal: a double-blind, randomized, clinical trial. J Addict Dis. 2012, 31:112-117. 10.1080\/10550887.2012.665728","journal-title":"J Addict Dis"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2013.05.010","article-title":"Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial","volume":"133","author":"Lofwall MR","year":"2013","unstructured":"Lofwall MR, Babalonis S, Nuzzo PA, Siegel A, Campbell C, Walsh SL. Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial. Drug Alcohol Depend. 2013, 133:188-197. 10.1016\/j.drugalcdep.2013.05.010","journal-title":"Drug Alcohol Depend"},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.5055\/jom.2013.0145","article-title":"Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects","volume":"9","author":"Chawla JM","year":"2013","unstructured":"Chawla JM, Pal H, Lal R, Jain R, Schooler N, Balhara YP. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects. J Opioid Manag. 2013, 9:35-41.","journal-title":"J Opioid Manag"},{"key":"ref42","article-title":"Tramadol vs. buprenorphine for the treatment of opioid dependence: a comparative study","volume":"6","author":"Pahwa M","year":"2015","unstructured":"Pahwa M, Sidhu BS, Raj R, Kumar E. Tramadol vs. buprenorphine for the treatment of opioid dependence: a comparative study. J Addict Res Ther. 2015, 6:2.","journal-title":"J Addict Res Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1838","article-title":"Efficacy of tramadol extended-release for opioid withdrawal: a randomized clinical trial","volume":"74","author":"Dunn KE","year":"2017","unstructured":"Dunn KE, Tompkins DA, Bigelow GE, Strain EC. Efficacy of tramadol extended-release for opioid withdrawal: a randomized clinical trial. JAMA Psychiatry. 2017, 74:885-893. 10.1001\/jamapsychiatry.2017.1838","journal-title":"JAMA Psychiatry"},{"key":"ref44","article-title":"Tramadol versus methadone for the management of acute opioid withdrawal: an add-on study","volume":"11","author":"Salehi M","year":"2006","unstructured":"Salehi M, Amanatkar M, Barekateyn M. Tramadol versus methadone for the management of acute opioid withdrawal: an add-on study. J Res Med Sci. 2006, 11:185-189.","journal-title":"J Res Med Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1300\/j069v22n04_03","article-title":"The use of tramadol for acute heroin withdrawal: a comparison to clonidine","volume":"22","author":"Sobey PW","year":"2003","unstructured":"Sobey PW, Parran TV Jr, Grey SF, Adelman CL, Yu J. The use of tramadol for acute heroin withdrawal: a comparison to clonidine. J Addict Dis. 2003, 22:13-25. 10.1300\/j069v22n04_03","journal-title":"J Addict Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.67","article-title":"Use of buprenorphine in the treatment of opioid addiction. II. physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal","volume":"47","author":"Fudala PJ","year":"1990","unstructured":"Fudala PJ, Jaffe JH, Dax EM, Johnson RE. Use of buprenorphine in the treatment of opioid addiction. II. physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal. Clin Pharmacol Ther. 1990, 47:525-534. 10.1038\/clpt.1990.67","journal-title":"Clin Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36705-tramadol-for-the-management-of-opioid-withdrawal-a-systematic-review-of-randomized-clinical-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:19Z","timestamp":1707506359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36705-tramadol-for-the-management-of-opioid-withdrawal-a-systematic-review-of-randomized-clinical-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,11]]},"references-count":46,"URL":"https:\/\/doi.org\/10.7759\/cureus.9128","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,11]]}}}